Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.
about
Virulence factors of medically important fungiCryptococcal cell morphology affects host cell interactions and pathogenicityNeuromeningeal cryptococcosis in sub-Saharan Africa: Killer disease with sparse dataMelanization of Cryptococcus neoformans in murine infection.Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status.Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.Cryptococcal meningitis: epidemiology and therapeutic options.Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in miceOrgan-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infectionHost-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and diseaseCryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfectionAmphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrationsThe cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes.Prevalence of cryptococcal meningitis among people living with human immunodeficiency virus/acquired immunodeficiency syndrome in a Tertiary Care Hospital, Southern Odisha, IndiaInterdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected UgandansCryptococcal Meningitis in HIV-Infected Patients.Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.Immunoregulation by capsular components of Cryptococcus neoformans.Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformansThe contribution of melanin to microbial pathogenesis.Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitroVariation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharideOpsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodiesPeptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody.Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro.Extracellular proteins of Cryptococcus neoformans and host antibody responseImmunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis.Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection.Screening for cryptococcal antigenemia in anti-retroviral naïve AIDS patients in benin city, Nigeria.Identification and Characterization of VNI/VNII and Novel VNII/VNIV Hybrids and Impact of Hybridization on Virulence and Antifungal Susceptibility Within the C. neoformans/C. gattii Species ComplexPurification and characterization of a 43-kilodalton extracellular serine proteinase from Cryptococcus neoformans.Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy.
P2860
Q24683790-A4203F6E-7021-47D2-8F5F-98F4433E5D7EQ27314538-082C8E47-5C48-4D1E-99A3-46D0BA0880D2Q30934853-E9510A9D-73C1-4748-B4F6-645DDF241CFCQ31951268-D1D23552-F4CD-4C7E-8E44-5F16F28D5E11Q33556039-D643BA53-1E9F-49AF-BC37-0F1FF07D6C14Q33585837-5C6F18D2-E250-479A-B8B2-CF9E1E278D21Q33598508-66BAE2CD-76DA-4080-8E98-89FDFB09BC40Q33633343-DB921D33-7838-4D83-B2AC-700BA75E3151Q33693515-042D6375-8AA8-4015-AA9C-DD18B3D8249CQ33751509-CE912B8C-ADF6-4116-A73D-9D556FC264BBQ33766953-C0F3C692-190A-4400-96D6-B53C7EBCBB2AQ33925636-E03C2128-2CBF-4427-90F4-67BDAFD84E22Q33946649-F3DA9C30-D013-4799-9574-365ECBFBAF69Q33975989-8F38F785-2AC8-49A8-A624-1980DA236ECBQ34000431-FBFD51B2-37B4-4E99-8085-F2FD02114CA4Q34002859-6C6BA0F5-EC43-461B-B8B3-6E9533ED44B9Q34009212-93F154A7-E23D-481D-BFC4-B1FE053225B3Q34009446-B0EE3765-6036-4B2D-A65C-B3B69C2FC51FQ34072411-BC79A917-F8B9-4263-BB69-DC92D0A5604BQ34092284-00AFE730-2142-4722-8DFA-FEA190B5C70DQ34121516-75790F0D-5EC5-44DF-AF27-4774A093914DQ34142491-FCF53DCA-DC1A-4BDC-897D-12F33CC8C882Q34155052-E489E073-DEEC-433B-9E6E-4F807BC031ABQ34680995-AC74B25F-9FA9-4B02-A078-5FC20BC5FBC3Q35098810-2F562EA1-512A-4A04-B6D7-B1B9A76CDBD4Q35132244-E3DEFEC9-6362-4E75-A00D-216E7B2A1532Q35411136-290418A5-3314-4E96-883A-FD224B04F674Q35428887-2BFD92C5-5393-4A85-9488-B648F95A218EQ35475646-E23C0B50-A777-4532-9134-FEF3A66A80EDQ35514947-D2A72E5B-6D48-4639-BE5A-9EA192684DE8Q35544888-33F4C87E-4024-4650-BF3B-92E1214CFBAAQ35547271-1E846A4E-7F98-4195-94E7-062FF93FF023Q35550533-9943F4B0-9E03-4BEE-90E5-2E82EB7158ADQ35773483-1EC73EB9-BA2A-4CDB-BCFE-13AAF68D2F82Q35978710-2DB61CEB-AE71-4FE9-B5D5-85E1222A4FE5Q36088621-5E1D0C36-9E49-4D94-B96B-B4B6EA0324EBQ36168992-4A59D04B-140C-4E37-91DC-90BEF8BF3B30Q36239825-78B630F2-8DA5-46EB-93CF-7776F96572DBQ36366474-0434E532-804D-4229-BAF1-B83E6E24BB60Q36376827-3000153D-D8CE-4C91-A3C8-549D817B1914
P2860
Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Estimation of the prevalence o ...... ciency virus in New York City.
@en
Estimation of the prevalence o ...... ciency virus in New York City.
@nl
type
label
Estimation of the prevalence o ...... ciency virus in New York City.
@en
Estimation of the prevalence o ...... ciency virus in New York City.
@nl
prefLabel
Estimation of the prevalence o ...... ciency virus in New York City.
@en
Estimation of the prevalence o ...... ciency virus in New York City.
@nl
P356
P1476
Estimation of the prevalence o ...... ciency virus in New York City.
@en
P2093
Casadevall A
P304
P356
10.1093/CLINIDS/19.6.1029
P407
P577
1994-12-01T00:00:00Z